E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/17/2024 in the Prospect News Emerging Markets Daily.

New Issue: China Resources Pharmaceutical issues RMB 3 billion of bonds in two parts

Chicago, April 17 – China Resources Pharmaceutical Group Ltd. said its non-wholly owned subsidiary, China Resources Pharmaceutical Commercial Group Co. Ltd., issued RMB 3 billion of bonds in two parts, according to a notice.

The deal includes 2.45% three-year bonds and 2.63% five-year bonds.

Proceeds are being used to repay interest-bearing debt.

This is the company’s first issuance for the year.

The company is based in Hong Kong. It engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products.

Issuer:China Resources Pharmaceutical Commercial Group Co. Ltd.
Amount:RMB 3 billion
Issue:Corporate bonds
Announcement date:April 17
Three-year bonds
Tenor:Three years
Coupon:2.45%
Five-year
Tenor:Five years
Coupon:2.63%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.